Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 14 Lung Neoplasms 11 Breast Neoplasms 9 Colorectal Neoplasms 8 Prostatic Neoplasms 7 Stomach Neoplasms 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Smoking Cessation 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic cancer, adult 2 Ovarian Neoplasms 2 Neoplastic Cells, Circulating 2 Motor Activity 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Endometrial Neoplasms 2 Disease 2 Wilms Tumor 1 Venous Thromboembolism 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1

Interventions

Temozolomide 159 Bevacizumab 69 Radiotherapy 68 Magnetic Resonance Spectroscopy 68 Irinotecan 31 Surgical Procedures, Operative 27 Radiation 24 Carboplatin 23 Specimen Handling 20 Carmustine 20 Blood Specimen Collection 20 Nivolumab 19 Aminolevulinic Acid 18 Biopsy 17 Lomustine 16 pembrolizumab 13 Radiotherapy, Intensity-Modulated 13 Cyclophosphamide 13 trametinib 12 fluorodopa F 18 12 X-Rays 12 Radiosurgery 12 Erlotinib Hydrochloride 12 Topotecan 11 Everolimus 11 Magnetic Resonance Imaging 10 IL13-PE38 10 dabrafenib 9 Etoposide 9 Drug Therapy 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Hematologic Tests × Clear all

NCT00985036 2012-04-24

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Marquette General Health System

Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡